 | • レポートコード：MRC2312MG12765 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のライブセル3Dカプセル化市場規模と予測を収録しています。・世界のライブセル3Dカプセル化市場：売上、2018年-2023年、2024年-2029年 ・世界のライブセル3Dカプセル化市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のライブセル3Dカプセル化市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アルギン酸」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ライブセル3Dカプセル化のグローバル主要企業は、Viacyte, Inc.、 Living Cell Technologies Ltd.、 Sigilon Therapeutics, Inc、 Sernova Corporation、 PharmaCyte Biotech Inc、 Gloriana Therapeutics、 Kadimastem、 Beta-O2 Technologies, Inc.、 Altucell, Inc.、 Diatranz Otsuka Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ライブセル3Dカプセル化のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のライブセル3Dカプセル化市場：タイプ別、2018年-2023年、2024年-2029年 世界のライブセル3Dカプセル化市場：タイプ別市場シェア、2022年 ・アルギン酸、キトサン、セルロース、その他 世界のライブセル3Dカプセル化市場：用途別、2018年-2023年、2024年-2029年 世界のライブセル3Dカプセル化市場：用途別市場シェア、2022年 ・糖尿病、癌、てんかん、パーキンソン病、その他 世界のライブセル3Dカプセル化市場：地域・国別、2018年-2023年、2024年-2029年 世界のライブセル3Dカプセル化市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるライブセル3Dカプセル化のグローバル売上、2018年-2023年 ・主要企業におけるライブセル3Dカプセル化のグローバル売上シェア、2022年 ・主要企業におけるライブセル3Dカプセル化のグローバル販売量、2018年-2023年 ・主要企業におけるライブセル3Dカプセル化のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Viacyte, Inc.、 Living Cell Technologies Ltd.、 Sigilon Therapeutics, Inc、 Sernova Corporation、 PharmaCyte Biotech Inc、 Gloriana Therapeutics、 Kadimastem、 Beta-O2 Technologies, Inc.、 Altucell, Inc.、 Diatranz Otsuka Ltd ************************************************************* ・調査・分析レポートの概要 ライブセル3Dカプセル化市場の定義 市場セグメント 世界のライブセル3Dカプセル化市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のライブセル3Dカプセル化市場規模 世界のライブセル3Dカプセル化市場規模：2022年 VS 2029年 世界のライブセル3Dカプセル化市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのライブセル3Dカプセル化の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のライブセル3Dカプセル化製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：アルギン酸、キトサン、セルロース、その他 ライブセル3Dカプセル化のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：糖尿病、癌、てんかん、パーキンソン病、その他 ライブセル3Dカプセル化の用途別グローバル売上・予測 ・地域別市場分析 地域別ライブセル3Dカプセル化市場規模 2022年と2029年 地域別ライブセル3Dカプセル化売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Viacyte, Inc.、 Living Cell Technologies Ltd.、 Sigilon Therapeutics, Inc、 Sernova Corporation、 PharmaCyte Biotech Inc、 Gloriana Therapeutics、 Kadimastem、 Beta-O2 Technologies, Inc.、 Altucell, Inc.、 Diatranz Otsuka Ltd ... |
This research report provides a comprehensive analysis of the Live Cell 3D Encapsulation market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Live Cell 3D Encapsulation market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Live Cell 3D Encapsulation, challenges faced by the industry, and potential opportunities for market players.
The global Live Cell 3D Encapsulation market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Live Cell 3D Encapsulation market presents opportunities for various stakeholders, including Diabetes, Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Live Cell 3D Encapsulation market. Additionally, the growing consumer demand present avenues for market expansion.
The global Live Cell 3D Encapsulation market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Live Cell 3D Encapsulation market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Live Cell 3D Encapsulation market.
Market Overview: The report provides a comprehensive overview of the Live Cell 3D Encapsulation market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Alginate, Chitosan), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Live Cell 3D Encapsulation market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Live Cell 3D Encapsulation market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Live Cell 3D Encapsulation market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Live Cell 3D Encapsulation market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Live Cell 3D Encapsulation market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Live Cell 3D Encapsulation market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Live Cell 3D Encapsulation, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Live Cell 3D Encapsulation market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Live Cell 3D Encapsulation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Alginate
Chitosan
Cellulose
Others
Market segment by Application
Diabetes
Cancer
Epilepsy
Parkinson
Others
Global Live Cell 3D Encapsulation Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live Cell 3D Encapsulation, market overview.
Chapter 2: Global Live Cell 3D Encapsulation market size in revenue.
Chapter 3: Detailed analysis of Live Cell 3D Encapsulation company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live Cell 3D Encapsulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Live Cell 3D Encapsulation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Cell 3D Encapsulation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Cell 3D Encapsulation Overall Market Size
2.1 Global Live Cell 3D Encapsulation Market Size: 2022 VS 2029
2.2 Global Live Cell 3D Encapsulation Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Live Cell 3D Encapsulation Players in Global Market
3.2 Top Global Live Cell 3D Encapsulation Companies Ranked by Revenue
3.3 Global Live Cell 3D Encapsulation Revenue by Companies
3.4 Top 3 and Top 5 Live Cell 3D Encapsulation Companies in Global Market, by Revenue in 2022
3.5 Global Companies Live Cell 3D Encapsulation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Live Cell 3D Encapsulation Players in Global Market
3.6.1 List of Global Tier 1 Live Cell 3D Encapsulation Companies
3.6.2 List of Global Tier 2 and Tier 3 Live Cell 3D Encapsulation Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Live Cell 3D Encapsulation Market Size Markets, 2022 & 2029
4.1.2 Alginate
4.1.3 Chitosan
4.1.4 Cellulose
4.1.5 Others
4.2 By Type – Global Live Cell 3D Encapsulation Revenue & Forecasts
4.2.1 By Type – Global Live Cell 3D Encapsulation Revenue, 2018-2023
4.2.2 By Type – Global Live Cell 3D Encapsulation Revenue, 2024-2029
4.2.3 By Type – Global Live Cell 3D Encapsulation Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Live Cell 3D Encapsulation Market Size, 2022 & 2029
5.1.2 Diabetes
5.1.3 Cancer
5.1.4 Epilepsy
5.1.5 Parkinson
5.1.6 Others
5.2 By Application – Global Live Cell 3D Encapsulation Revenue & Forecasts
5.2.1 By Application – Global Live Cell 3D Encapsulation Revenue, 2018-2023
5.2.2 By Application – Global Live Cell 3D Encapsulation Revenue, 2024-2029
5.2.3 By Application – Global Live Cell 3D Encapsulation Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Live Cell 3D Encapsulation Market Size, 2022 & 2029
6.2 By Region – Global Live Cell 3D Encapsulation Revenue & Forecasts
6.2.1 By Region – Global Live Cell 3D Encapsulation Revenue, 2018-2023
6.2.2 By Region – Global Live Cell 3D Encapsulation Revenue, 2024-2029
6.2.3 By Region – Global Live Cell 3D Encapsulation Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Live Cell 3D Encapsulation Revenue, 2018-2029
6.3.2 US Live Cell 3D Encapsulation Market Size, 2018-2029
6.3.3 Canada Live Cell 3D Encapsulation Market Size, 2018-2029
6.3.4 Mexico Live Cell 3D Encapsulation Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Live Cell 3D Encapsulation Revenue, 2018-2029
6.4.2 Germany Live Cell 3D Encapsulation Market Size, 2018-2029
6.4.3 France Live Cell 3D Encapsulation Market Size, 2018-2029
6.4.4 U.K. Live Cell 3D Encapsulation Market Size, 2018-2029
6.4.5 Italy Live Cell 3D Encapsulation Market Size, 2018-2029
6.4.6 Russia Live Cell 3D Encapsulation Market Size, 2018-2029
6.4.7 Nordic Countries Live Cell 3D Encapsulation Market Size, 2018-2029
6.4.8 Benelux Live Cell 3D Encapsulation Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Live Cell 3D Encapsulation Revenue, 2018-2029
6.5.2 China Live Cell 3D Encapsulation Market Size, 2018-2029
6.5.3 Japan Live Cell 3D Encapsulation Market Size, 2018-2029
6.5.4 South Korea Live Cell 3D Encapsulation Market Size, 2018-2029
6.5.5 Southeast Asia Live Cell 3D Encapsulation Market Size, 2018-2029
6.5.6 India Live Cell 3D Encapsulation Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Live Cell 3D Encapsulation Revenue, 2018-2029
6.6.2 Brazil Live Cell 3D Encapsulation Market Size, 2018-2029
6.6.3 Argentina Live Cell 3D Encapsulation Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Live Cell 3D Encapsulation Revenue, 2018-2029
6.7.2 Turkey Live Cell 3D Encapsulation Market Size, 2018-2029
6.7.3 Israel Live Cell 3D Encapsulation Market Size, 2018-2029
6.7.4 Saudi Arabia Live Cell 3D Encapsulation Market Size, 2018-2029
6.7.5 UAE Live Cell 3D Encapsulation Market Size, 2018-2029
7 Live Cell 3D Encapsulation Companies Profiles
7.1 Viacyte, Inc.
7.1.1 Viacyte, Inc. Company Summary
7.1.2 Viacyte, Inc. Business Overview
7.1.3 Viacyte, Inc. Live Cell 3D Encapsulation Major Product Offerings
7.1.4 Viacyte, Inc. Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.1.5 Viacyte, Inc. Key News & Latest Developments
7.2 Living Cell Technologies Ltd.
7.2.1 Living Cell Technologies Ltd. Company Summary
7.2.2 Living Cell Technologies Ltd. Business Overview
7.2.3 Living Cell Technologies Ltd. Live Cell 3D Encapsulation Major Product Offerings
7.2.4 Living Cell Technologies Ltd. Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.2.5 Living Cell Technologies Ltd. Key News & Latest Developments
7.3 Sigilon Therapeutics, Inc
7.3.1 Sigilon Therapeutics, Inc Company Summary
7.3.2 Sigilon Therapeutics, Inc Business Overview
7.3.3 Sigilon Therapeutics, Inc Live Cell 3D Encapsulation Major Product Offerings
7.3.4 Sigilon Therapeutics, Inc Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.3.5 Sigilon Therapeutics, Inc Key News & Latest Developments
7.4 Sernova Corporation
7.4.1 Sernova Corporation Company Summary
7.4.2 Sernova Corporation Business Overview
7.4.3 Sernova Corporation Live Cell 3D Encapsulation Major Product Offerings
7.4.4 Sernova Corporation Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.4.5 Sernova Corporation Key News & Latest Developments
7.5 PharmaCyte Biotech Inc
7.5.1 PharmaCyte Biotech Inc Company Summary
7.5.2 PharmaCyte Biotech Inc Business Overview
7.5.3 PharmaCyte Biotech Inc Live Cell 3D Encapsulation Major Product Offerings
7.5.4 PharmaCyte Biotech Inc Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.5.5 PharmaCyte Biotech Inc Key News & Latest Developments
7.6 Gloriana Therapeutics
7.6.1 Gloriana Therapeutics Company Summary
7.6.2 Gloriana Therapeutics Business Overview
7.6.3 Gloriana Therapeutics Live Cell 3D Encapsulation Major Product Offerings
7.6.4 Gloriana Therapeutics Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.6.5 Gloriana Therapeutics Key News & Latest Developments
7.7 Kadimastem
7.7.1 Kadimastem Company Summary
7.7.2 Kadimastem Business Overview
7.7.3 Kadimastem Live Cell 3D Encapsulation Major Product Offerings
7.7.4 Kadimastem Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.7.5 Kadimastem Key News & Latest Developments
7.8 Beta-O2 Technologies, Inc.
7.8.1 Beta-O2 Technologies, Inc. Company Summary
7.8.2 Beta-O2 Technologies, Inc. Business Overview
7.8.3 Beta-O2 Technologies, Inc. Live Cell 3D Encapsulation Major Product Offerings
7.8.4 Beta-O2 Technologies, Inc. Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.8.5 Beta-O2 Technologies, Inc. Key News & Latest Developments
7.9 Altucell, Inc.
7.9.1 Altucell, Inc. Company Summary
7.9.2 Altucell, Inc. Business Overview
7.9.3 Altucell, Inc. Live Cell 3D Encapsulation Major Product Offerings
7.9.4 Altucell, Inc. Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.9.5 Altucell, Inc. Key News & Latest Developments
7.10 Diatranz Otsuka Ltd
7.10.1 Diatranz Otsuka Ltd Company Summary
7.10.2 Diatranz Otsuka Ltd Business Overview
7.10.3 Diatranz Otsuka Ltd Live Cell 3D Encapsulation Major Product Offerings
7.10.4 Diatranz Otsuka Ltd Live Cell 3D Encapsulation Revenue in Global Market (2018-2023)
7.10.5 Diatranz Otsuka Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer